612 related articles for article (PubMed ID: 18946337)
1. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
Dragun D
Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
[TBL] [Abstract][Full Text] [Related]
2. Non-HLA antibodies post-transplantation: clinical relevance and treatment in solid organ transplantation.
Dragun D; Hegner B
Contrib Nephrol; 2009; 162():129-39. PubMed ID: 19001820
[TBL] [Abstract][Full Text] [Related]
3. Relevance of MICA and other non-HLA antibodies in clinical transplantation.
Sumitran-Holgersson S
Curr Opin Immunol; 2008 Oct; 20(5):607-13. PubMed ID: 18675346
[TBL] [Abstract][Full Text] [Related]
4. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation.
Carter V; Shenton BK; Jaques B; Turner D; Talbot D; Gupta A; Chapman CE; Matthews CJ; Cavanagh G
Transplant Proc; 2005 Mar; 37(2):654-7. PubMed ID: 15848491
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
6. Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection.
Dragun D; Catar R; Kusch A; Heidecke H; Philippe A
Hum Immunol; 2012 Dec; 73(12):1282-6. PubMed ID: 22819838
[TBL] [Abstract][Full Text] [Related]
7. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
Dragun D; Catar R; Philippe A
Kidney Int; 2016 Aug; 90(2):280-288. PubMed ID: 27188505
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of anti-HLA antibodies via proteasome inhibition.
Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
Delville M; Charreau B; Rabant M; Legendre C; Anglicheau D
Hum Immunol; 2016 Nov; 77(11):1055-1062. PubMed ID: 27237040
[TBL] [Abstract][Full Text] [Related]
10. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
11. Immunological function of the endothelial cell within the setting of organ transplantation.
Taflin C; Charron D; Glotz D; Mooney N
Immunol Lett; 2011 Sep; 139(1-2):1-6. PubMed ID: 21641935
[TBL] [Abstract][Full Text] [Related]
12. Solid phase assays for HLA antibody detection in clinical transplantation.
Tait BD
Curr Opin Immunol; 2009 Oct; 21(5):573-7. PubMed ID: 19765965
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms and role of HLA and non-HLA alloantibodies.
Tinckam KJ; Chandraker A
Clin J Am Soc Nephrol; 2006 May; 1(3):404-14. PubMed ID: 17699239
[TBL] [Abstract][Full Text] [Related]
14. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway.
Narayanan K; Jendrisak MD; Phelan DL; Mohanakumar T
Transpl Immunol; 2006 Jan; 15(3):187-97. PubMed ID: 16431285
[TBL] [Abstract][Full Text] [Related]
15. Preformed cytotoxic antibodies in potential allograft recipients: recent data.
Cecka JM; Zhang Q; Reed EF
Hum Immunol; 2005 Apr; 66(4):343-9. PubMed ID: 15866696
[TBL] [Abstract][Full Text] [Related]
16. Anti-major histocompatibility complex class I-related chain A antibodies in organ transplantation.
Morales-Buenrostro LE; Alberú J
Transplant Rev (Orlando); 2008 Jan; 22(1):27-38. PubMed ID: 18631856
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cells as targets of allograft rejection.
Glotz D; Lucchiari N; Pegaz-Fiornet B; Suberbielle-Boissel C
Transplantation; 2006 Jul; 82(1 Suppl):S19-21. PubMed ID: 16829788
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus.
El-Awar NR; Akaza T; Terasaki PI; Nguyen A
Transplantation; 2007 Aug; 84(4):532-40. PubMed ID: 17713439
[TBL] [Abstract][Full Text] [Related]
19. Detailed examination of HLA antibody development on renal allograft failure and function.
Zhu L; Lee PC; Everly MJ; Terasaki PI
Clin Transpl; 2008; ():171-87. PubMed ID: 19711514
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
Rose ML; Smith JD
Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
